Filing Details

Accession Number:
0001209191-23-050530
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-09-25 20:30:09
Reporting Period:
2023-09-21
Accepted Time:
2023-09-25 20:30:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1492674 T2 Biosystems Inc. TTOO Surgical & Medical Instruments & Apparatus (3841) 204827488
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1637591 L.p. Iii Partners Crg 1000 Main Street, Suite 2500
Houston TX 77002
No No Yes No
1651357 L.p. (A) Fund Parallel - Iii Partners Crg 1000 Main Street, Suite 2500
Houston TX 77002
No No Yes No
1702352 L.p. Group Cr 1000 Main Street, Suite 2500
Houston TX 77002
No No Yes No
1767509 L.p. I Aiv Lev (Cayman) Iii Partners Crg 1000 Main Street, Suite 2500
Houston TX 77002
No No Yes No
1767510 L.p. I Aiv Unlev (Cayman) Iii Partners Crg 1000 Main Street, Suite 2500
Houston TX 77002
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-09-21 2,534,754 $0.30 9,538,970 No 4 S Indirect By CRG Partners III L.P.
Common Stock Disposition 2023-09-21 1,578,419 $0.30 5,940,018 No 4 S Indirect By CRG Partners III ? Parallel Fund ?A? L.P.
Common Stock Disposition 2023-09-21 506,951 $0.30 1,907,794 No 4 S Indirect By CRG Partners III (Cayman) Unlev AIV I L.P.
Common Stock Disposition 2023-09-21 1,718,087 $0.30 6,465,629 No 4 S Indirect By CRG Partners III (Cayman) Lev AIV I L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By CRG Partners III L.P.
No 4 S Indirect By CRG Partners III ? Parallel Fund ?A? L.P.
No 4 S Indirect By CRG Partners III (Cayman) Unlev AIV I L.P.
No 4 S Indirect By CRG Partners III (Cayman) Lev AIV I L.P.
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $0.2806 to $0.333, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth herein.
  2. CR Group L.P. may be deemed to beneficially own these shares by virtue of its position as the investment manager for the CRG Entities.